Literature DB >> 31550052

Factors affecting mortality of refractory status epilepticus.

Isil Tatlidil1, Hatice S Ture2, Galip Akhan2.   

Abstract

OBJECTIVE: The aim of this study was to determine the factors affecting the mortality of refractory status epilepticus (RSE) in comparison with non-refractory status epilepticus (non-RSE). MATERIAL-
METHOD: Included in this retrospective study were 109 status epilepticus cases who were hospitalized in the neurological intensive care unit Katip Celebi University. Fifty-two were RSE and 57 were non-RSE. All clinical data were gathered from the hospital archives. Factors which may cause mortality were categorized for statistical analysis.
RESULTS: While elderly age, continuous clinical seizure activity, absence of former seizure, infection, prolonged stay of ICU, anesthesia, and cardiac comorbidity were significantly related to mortality in the RSE subgroup, potentially fatal accompanying diseases were significantly related to mortality in the non-RSE subgroup. No significant relationship was found between mortality and refractoriness. Multivariate analysis revealed that a Glasgow Coma Score (GCS) at presentation of 8 or lower was the independent predictor of mortality both in the general SE population (P = .017) and in the RSE subgroup (P = .007). Intubation (P = .011) and hypotension (P = .011) were the other independent predictors of mortality in the general SE population. No independent predictor of mortality was detected in the non-RSE subgroup. DISCUSSION/
CONCLUSION: Intubation, hypotension, and a low GCS at presentation could be the main factors which could alert clinicians of an increased risk of mortality in SE patients. Although non-RSE and RSE had similar rates of mortality in the ICU, the mortality-related factors of SE vary in the RSE and the non-RSE subgroups.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  demographics; factors; mortality; non-refractory status epilepticus; refractory status epilepticus; status epilepticus

Mesh:

Substances:

Year:  2019        PMID: 31550052     DOI: 10.1111/ane.13173

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Early Combination Therapy of Ketamine and Midazolam in Patients with Refractory Status Epilepticus in Hemodynamic Unstable State.

Authors:  Jung-Won Choi; Jung-Won Shin
Journal:  J Epilepsy Res       Date:  2021-12-31

2.  Only a Fine Line Separates Genius, Insanity, and Anesthetic Medication for Coma Induction in Status Epilepticus.

Authors:  Jong Woo Lee
Journal:  Epilepsy Curr       Date:  2021-09-22       Impact factor: 7.500

3.  Ketamine in adult super-refractory status epilepticus: Efficacy analysis on a prospective registry.

Authors:  Leonardo Caranzano; Jan Novy; Andrea O Rossetti
Journal:  Acta Neurol Scand       Date:  2022-03-11       Impact factor: 3.915

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.